Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Metastatic Malignant Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03260322
What this trial is testing

A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Global Development, Inc. 169
Testing effectiveness (Phase 2)Looking for participantsNCT07601737
What this trial is testing

Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma (HNSCC)Head & Neck Cancer+1 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 182
Testing effectiveness (Phase 2)UnknownNCT02993653
What this trial is testing

Intensity-modulated Radiotherapy Protocol in Cervix Cancer

Who this might be right for
Radiation
Seoul St. Mary's Hospital 80
Large-scale testing (Phase 3)Looking for participantsNCT06762405
What this trial is testing

PRODIGE 90 - (FFCD 2204) Neoadjuvant Dostarlimab with Short Course Radiotherapy in a Watch-and-wait Strategy for Microsatellite Unstable or Mismatch Repair-deficient Locally Advanced Rectal Cancer Patients

Who this might be right for
Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H)
Centre Hospitalier Universitaire Dijon 68
Not applicableActive Not RecruitingNCT04423731
What this trial is testing

Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer (NORPACT-2)

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaChemotherapy EffectBorderline Resectable Pancreatic Adenocarcinoma+1 more
Oslo University Hospital 251
Early research (Phase 1)Study completedNCT01106872
What this trial is testing

Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas

Who this might be right for
SarcomaSoft Tissue SarcomaLocally Advanced Sarcoma+2 more
Mohammed M Milhem 47
Large-scale testing (Phase 3)Looking for participantsNCT03592472
What this trial is testing

Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)

Who this might be right for
Renal Cell Carcinoma
Xynomic Pharmaceuticals, Inc. 413
Testing effectiveness (Phase 2)Study completedNCT00206505
What this trial is testing

Neoadjuvant Taxotere

Who this might be right for
Breast Cancer
Baylor Breast Care Center 40
Early research (Phase 1)Study completedNCT00732056
What this trial is testing

GRN163L With Paclitaxel and Bevacizumab to Treat Patients With Locally Recurrent Or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Geron Corporation 24
Early research (Phase 1)Study completedNCT00622622
What this trial is testing

Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Wakayama Medical University 21
Large-scale testing (Phase 3)Study completedNCT01815853
What this trial is testing

Neoadjuvant Chemoradiotherapy vs. Chemotherapy Followed by Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Sun Yat-sen University 620
Testing effectiveness (Phase 2)Study completedNCT00626639
What this trial is testing

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy

Who this might be right for
MucositisHead and Neck Cancer
Swedish Orphan Biovitrum 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT04999969
What this trial is testing

Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours

Who this might be right for
Locally Advanced or Metastatic Solid Tumours
AstraZeneca 126
Large-scale testing (Phase 3)Ended earlyNCT03970694
What this trial is testing

Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy For Unresectable Locally Advanced Colon Cancer

Who this might be right for
Colon Cancer
Sun Yat-sen University 49
Not applicableUnknownNCT06096545
What this trial is testing

Axillary Management After Neoadjuvant Chemotherapy

Who this might be right for
Breast CancerBreast NeoplasmsBreast Cancer Female
Medipol University 50
Testing effectiveness (Phase 2)Ended earlyNCT03330405
What this trial is testing

Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors

Who this might be right for
Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors
Pfizer 223
Testing effectiveness (Phase 2)Looking for participantsNCT06794229
What this trial is testing

Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis

Who this might be right for
Locally Advanced Renal Cell Carcinoma
Qian Qin 69
Large-scale testing (Phase 3)Not Yet RecruitingNCT07074353
What this trial is testing

Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Zhejiang Cancer Hospital 360
Early research (Phase 1)WithdrawnNCT03245177
What this trial is testing

Pembrolizumab in Combination With Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Prof Corinne Faivre-Finn
Large-scale testing (Phase 3)Study completedNCT00002777
What this trial is testing

Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 342
Next Page